🟢 100/100

This product looks safe

  • No ingredients exceed tolerable upper intake levels
  • 100% of ingredients have research evidence
A Label Compliance Grade

Product Label

📸

Have a supplement label? Find it here.

Upload a photo of any supplement label to search our database of 92,312 products.

Label Data

1 Tablet(s) Serving Size
Non-Nutrient/Non-Botanical Product Type
100% Evidence Coverage

Supplement Facts — Evidence Check

0.5 mg
📊 Market median: 3.0mg (984 products) 📚 236 studies (Tier A: 2, B: 109)
This product: 0.5mg UL 10mg

Other Ingredients

Monk Fruit Cellulose Vegetarian Stearate Silica

Label Claims — Verification

All Other
All Other (100% of products) Structure/Function (86% of products) Nutrient (7% of products)

Target Groups

Vegan Vegetarian Adult (18 - 50 Years) Kosher Women (not pregnant or lactating) Gluten Free Sugar Free

Product Information

📋 Directions for Use

Suggested Use: As a dietary supplement, take one (1) chewable tablet 30 to 60 minutes before bedtime, or as directed by a healthcare practitioner.

⚠️ Warnings & Precautions

Warning: Not intended for pregnant or nursing women. If you are taking any medication or you have a medical condition, consult your doctor before use.

Do not drive or operate machinery when taking this product.

Keep this product out of the reach of children.

🧪 Formulation Notes

No gluten No lactose No artificial colors No artificial flavors No animal derivatives No sugar or starch No gelatin No yeast

Vegan

NSKC (New Square Rabbinical Kashrus Council) OU Pareve (Kosher)

Additional Information

Manufactured in a GMP certified facility in the USA

Freeda since 1928

NSKC (New Square Rabbinical Kashrus Council) OU Pareve (Kosher)

Store product at room temperature. Do not expose to excessive heat or moisture.

Product Details

UPC / SKU 7 58487 04020 9
DSLD Entry Date 2020-05-22
Product Type Non-Nutrient/Non-Botanical
Form Tablet or Pill
Brand Freeda
DSLD ID 221610
Data Updated 2026-04-11

Research Evidence

291 Research Sources
55 Avg Quality Score
129 Meta Analysis
93 Systematic Review
51 Rct
11 Clinical Trial
2 Other
2 Regulatory Source
1 Openfda Safety
A Interventions for preventing delirium in hospitalised non-ICU patients
Meta Analysis The Cochrane database of systematic reviews 2016
A Melatonin for preoperative and postoperative anxiety in adults
Meta Analysis The Cochrane database of systematic reviews 2020
A Effect of melatonin on quality of life and symptoms in patients with cancer: a systematic review and meta-analysis of randomised controlled trials
Meta Analysis BMJ open 2022
B Pharmacological interventions for prevention of weight gain in people with schizophrenia
Meta Analysis The Cochrane database of systematic reviews 2022
B Melatonin for pre- and postoperative anxiety in adults
Meta Analysis The Cochrane database of systematic reviews 2015
B Prevention of depression in adults with long-term physical conditions
Meta Analysis The Cochrane database of systematic reviews 2021
B Comparative effects of pharmacological interventions for the acute and long-term management of insomnia disorder in adults: a systematic review and network meta-analysis
Systematic Review Lancet (London, England) 2022
B Does melatonin administration reduce the incidence of postoperative delirium in adults? Systematic review and meta-analysis
Meta Analysis BMJ open 2023
B Second-generation antidepressants for preventing seasonal affective disorder in adults
Meta Analysis The Cochrane database of systematic reviews 2015
B Interventions for preventing type 2 diabetes in adults with mental disorders in low- and middle-income countries
Meta Analysis The Cochrane database of systematic reviews 2021
View all evidence for Melatonin →

Compare Similar Products

View all Melatonin products →